EU/3/04/242: Orphan designation for the treatment of mastocytosis

N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole

Table of contents

Overview

On 16 November 2004, orphan designation (EU/3/04/242) was granted by the European Commission to AB Science, France, for N-(methyl-diazacyclohexyl methylbenzamide)-azaphenyl-aminothiopyrrole for the treatment of mastocytosis.

Key facts

Active substance
N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole
Intended use
Treatment of mastocytosis
Orphan designation status
Positive
EU designation number
EU/3/04/242
Date of designation
16/11/2004
Sponsor
AB Science
3, avenue Gerorge
F-75008 Paris
France
Telephone: + 33 1 47 20 10 35
Telefax: + 33 1 47 20 24 11
E-mail: contact@ab-science.com

Documents related to this orphan designation evaluation

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

EU register of orphan medicines

The list of medicines that have received an orphan designation in the EU is available on the European Commission's website:

Related content

How useful was this page?

Add your rating
Average
2 ratings